Medtronic beats quarterly estimates on robust demand for heart devices
J.P. Morgan analyst Robbie Marcus said he expects "to see some scrutiny," as the outlook was reiterated despite the quarterly beat and an around 100-basis-point benefit from foreign exchange, adding…

